# UroViu

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uroviu

- Industry: Medical Devices & Equipment
- Headquarters: Los Altos, US
- Website: www.uroviu.com
- Latest round: Series A (Jul 27, 2022)
- Investors on record: 2

## About

Established in 2016 and based in Los Altos, US, UroViu is a developer of single-use endoscopy solution on the Urology and UroGynecology market. The company is headquartered in California with offices and production facilities across North America and Asia, and has obtained 20 granted patents. The founder and CEO of the company, Dr. Bruce OuYang, has a Ph.D. focused in Medical Imaging from University of Chicago. 

The company is mainly engaged in the research and development, production and sales of disposable endoscopic products, mainly product is a single-use endoscope in the series of Uro-G Cannula, Uro-N Cannula, Hystero-V and a reusable handle, carry both hysteroscopic and cystoscopic consumable tubes, can realize one machine for two uses.

## Funding rounds

- Series A, Jul 27, 2022 — Jiangsu Yahong Pharmaceutical Technology Co., Ltd., Hengxu Capital

## Investors

- Jiangsu Yahong Pharmaceutical Technology Co., Ltd. — Series A
- Hengxu Capital (https://capitalatlas.ai/funds/hengxu-capital) — Series A